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Abstract
This paper introduces a new approach to power analysis in the context of estim-
ating a local average treatment effect (LATE), where the study subjects exhibit
noncompliance with treatment assignment. As a result of distributional com-
plications in the LATE context, compared to the simple ATE context, there is
currently no standard method of power analysis for the LATE. Moreover, existing
methods and commonly used substitutes—which include instrumental variable
(IV), intent-to-treat (ITT), and scaled ATE power analyses—require specifying
generally unknown variance terms and/or rely upon strong and unrealistic as-
sumptions, thus providing unreliable guidance on the power of tests of the LATE.
This paper develops a new framework that uses standardized effect sizes to place
bounds on the power for the most commonly used estimator of the LATE, the
Wald IV estimator, whereby variance terms and distributional parameters need
not be specified nor assumed. Instead, in addition to the effect size, sample size,
and error tolerance parameters, the only other parameter that must be specified
by the researcher is the first-stage effect. Additional conditions can also be in-
troduced to further narrow the bounds on the power calculation. The result is
a generalized approach to power analysis in the LATE context that is simple to
implement. Software is provided to implement the methods.
Keywords: experimental design, local average treatment effects, noncompliance, principal
stratification, statistical power
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I. Introduction
Power analysis has long been recognized as a vital study design tool (Cohen, 1962). Run-
ning simple power analyses provides researchers with concrete and reliable information to
help determine their budgetary requirements, choose a sample size, and form reasonable
expectations on the magnitude of treatment effects they will be able to detect. This helps
researchers avoid an eventuality in which a study has failed to produce meaningful findings
not because there is nothing interesting to find but rather due to insufficient power to over-
come fundamentally noisy data. The results of a power analysis can also help researchers
avoid running certain studies altogether if the costs are simply too prohibitive in light of the
probability of successful detection of a meaningful effect. Yet various fields of research are
replete with studies that have failed to report power analyses and implemented drastically
under-powered designs (Tversky and Kahneman, 1971; Tsang et al., 2009). Indeed, many
researchers’ (and funders’) time, energy, and money has been put at risk by neglect of power
analysis in the early stages of research design.
In practice, however, power analyses can often be challenging to properly implement.
In the case of a simple research design involving a randomized treatment and the goal of
estimating an average treatment effect (ATE), a complication is the need, a priori, for
estimates of or assumptions about the variance of the outcome variable (Bloom, 2006; Duflo
et al., 2007). This complication in a simple ATE power analysis is well-known among applied
researchers. Fortunately, there also exist fixes for this problem, as will be described later.
Less well-known, however, is the extent to which similar complications become exacer-
bated in the context of estimating a local average treatment effect (LATE), where the study
subjects exhibit noncompliance with treatment assignment. Due to the existence of multiple
principal strata, distinct distributional behavior across those strata, and the focus on local
identification of the average treatment effect, the number of distributional parameters that
impact power vastly proliferates in the LATE context. In fact, the power of LATE hypo-
thesis tests not only depends upon the rate of compliance, with lower compliance resulting in
lower power, but is also impacted by the different means and variances of all of the principal
strata as well as the proportions of subjects belonging to each principal stratum.
As a result, there is currently no standard method of power analysis in the LATE context.
In addition, existing methods require specifying distributional assumptions that are difficult
to make and/or come with hidden, implicit assumptions about the various principal strata
that are unlikely to reflect the reality of one’s applied data. Recognizing the complexity of
LATE power analysis, some researchers also settle for performing scaled ATE or intent-to-
treat (ITT) power analyses even when their ultimate estimand of interest is the LATE—a
precarious practice given that, as shown later, the results of scaled ATE and ITT power
analyses can diverge substantially from the results of a LATE power analysis. This state of
affairs is problematic given how common noncompliance is in many research environments,
including field experiments, clinical trials, and randomized controlled trials (RCTs) using
encouragement designs. These types of studies also tend to be among the most expensive,
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generating strong incentives for well-calibrated power analyses.
This paper introduces a new approach to LATE power analysis. Specifically, by using a
standardized LATE effect size, this paper shows how bounds can be placed on the power for
the Wald IV estimator of the LATE whereby neither variance components nor patterns of
noncompliance and heterogeneity need to be specified. Instead, in addition to the effect size,
sample size, and error tolerance parameters, the only other parameter that must be specified
by the researcher is the first-stage effect. In contrast, nine other underlying parameters that
affect power need not be specified. This paper focuses on the Wald IV estimator because it
is the most accessible and commonly used estimator of the LATE among applied researchers.
In addition, in contrast to other estimators of the LATE, such as those based on maximum
likelihood estimation and Bayesian methods (e.g. Imbens and Rubin, 1997), the Wald IV
estimator is nonparametric.
As usual, the effect size and sample size parameters can be isolated in the power analysis
introduced in this paper, presenting formulas for minimum detectable effect sizes and neces-
sary sample sizes. Additional assumptions can also be made to further narrow the bounds on
the power calculation. The result is a generalized approach to power analysis in the LATE
context that is simultaneously conservative, disciplined, and simple to implement. The ap-
proach can also be extended to tests in fuzzy regression discontinuity designs (Hahn et al.,
2001) that use the instrumental variable (IV) estimator in the discontinuity window around
the threshold, as well as quasi-experiments that apply the IV framework to observational
data.
To introduce a frame of reference, Section II will briefly discuss power analysis in the
standard average treatment effect (ATE) context. Section III will then discuss the LATE, and
proceed to highlight problems with existing power analysis methods and general challenges
to analyzing power in the LATE context. Sections IV and V will present the new method
of LATE power analysis introduced by this paper. Section VI will provide an illustration
of how the method could be use in practice, by applying it in the context of the National
JTPA Study. Sections VII and VIII extend the framework to allow for covariate adjustment
and multi-valued treatments. Section IX concludes.
II. Power Analysis for Average Treatment Effects
Let random variables Y denote the outcome and D denote the treatment, and assume D is
binary. Further, let Yi(Di) denote the potential outcomes for unit i under control (Di = 0)
and treatment (Di = 1) conditions, respectively. Further, let Ŷ (0) and Ŷ (1) denote the
averages of the observed outcome Yi for those units assigned to the control and treatment
conditions, respectively, which constitute unbiased estimates of E[Yi(0)] and E[Yi(1)] given
random assignment of D and the stable unit treatment value assumption (SUTVA). As a
result, the difference-in-means estimator, δˆ = Ŷ (1)−Ŷ (0), is unbiased for the sample average
treatment effect (ATE), the true value of which is δ = E[Yi(1)]− E[Yi(0)].
As shown elsewhere (Cohen, 1988; Bloom, 2006; Duflo et al., 2007), given asymptotic
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normality of the ATE estimator, power analysis then proceeds with the following equation:
Φ
(
−c∗ + δ√
VN
)
+ Φ
(
−c∗ − δ√
VN
)
= 1− β
where Φ(•) denotes the standard normal cumulative distribution function, δ denotes a hy-
pothesized true ATE value, VN denotes the sampling variance of the ATE estimator (δˆ),
1− β denotes the power to correctly reject the hypothesis test (β denotes the type-II error
rate), and c∗ denotes the critical value corresponding to the tolerable type-I error rate (α)
and hypothesis test type. For the standard two-tailed test of the null hypothesis of zero
difference in means, c∗ = Φ−1(1 − α
2
). Conventionally, VN ≡ V ar(Yi(1))N1 +
V ar(Yi(0))
N0
, given N
units with N1 assigned to treatment and N0 = N −N1 assigned to control.1
In order to use the power formula above, the analyst must specify VN , which requires
explicitly or implicitly specifying the variances of Yi(0) and Yi(1). This requirement presents
a possibly serious practical complication. While previous studies and/or existing data can
often help to inform these variance specifications, there often do not exist any data that is
recent or closely related enough to serve as a useful benchmark, particularly in the case where
a researcher is interested in a novel outcome variable or new population of interest. One
might devise an idea, based on theoretical expectations, about what a conservative variance
might look like. However, in the very plausible case that these expectations are inaccurate,
too high a guess will lead to an overpowered study while too low a guess will lead to an
unsuccessful study. In both cases, the researcher’s resources are at risk of being wasted.
“Effect sizes” have long been established as the standard solution to this problem in
the ATE context (Cohen, 1988; Bloom, 2006; Duflo et al., 2007). In cases where the vari-
ances are unknown and/or absolute effect magnitudes are difficult to interpret, a common
recommendation is to employ the effect size δ
σ
—rather than the absolute effect δ—where σ
is the standard deviation of a reference outcome distribution. In other words, effect sizes are
measures of treatment effects that are standardized with reference to the distribution of the
outcome variable. Most commonly used is σ =
√
E[V ar(Yi|Di)], the expected within-group
standard deviation of the outcome. By employing effect sizes, the result is that the variance
terms in the power formula drop out, thus obviating the inconvenient need to estimate or
guess variance values. In addition, there exist general benchmarks for what constitutes a
small, medium, and large effect size (e.g. Cohen, 1988), and meta-analyses within individual
fields of study have enabled researchers to develop discipline-specific guidance on effect size
significance (Lipsey, 1990, Chapter 3).
III. Power in the LATE Context
A. Local Average Treatment Effect (LATE)
In many studies, the subjects exhibit noncompliance: some units assigned to the treatment
condition do not take the treatment, and/or some units assigned to the control condition
1Imbens and Rubin (2015) show that this formula for VN is conservative given complete randomization of
N units with a pre-determined number N1 assigned to treatment and N0 = N −N1 assigned to control.
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do take the treatment. This problem is pervasive across many research settings—including
field experiments, clinical trials, and RCTs using encouragement designs—as subjects often
cannot be forced to take the treatment, and some subjects are able to access the treatment
even when not assigned to it (Gerber and Green, 2012). In the presence of noncompliance,
the ATE generally cannot be identified. However, it is possible to identify a local average
treatment effect (LATE), which is the ATE for a particular subset of the population: the
compliers, or those who take the treatment when assigned to the treatment and do not
otherwise (Angrist et al., 1996). The compliers are one of three subsets, or principal strata,
in the population. The second is the never-takers, or those who never take the treatment
regardless of their assignment. The third is the always-takers, or those who always take the
treatment regardless of their assignment.2 In the case of one-sided noncompliance, the LATE
is the ATE for the treated (given no always-takers) or the ATE for the untreated (given no
never-takers).
The method presented in this paper begins with a standard identification and estima-
tion framework for the LATE introduced by Angrist et al. (1996). Let random variables
Y denote the outcome, D the treatment uptake, and Z the randomized treatment assign-
ment/encouragement. Assume D and Z are both binary. Further, define the potential out-
comes Di(Z) and Yi(Z,D), where Z and D correspond to the full treatment assignment and
uptake vectors across subjects, respectively. Following Angrist et al. (1996), the following
assumptions are made:
Assumption 1 (Stable Unit Treatment Value Assumption (SUTVA))
If Zi = Z
′
i, then Di(Z) = Di(Z
′).
If Zi = Z
′
i and Di = D
′
i, then Yi(Z,D) = Yi(Z
′,D′).
Assumption 2 (Random Assignment)
The treatment assignment Zi is random: P (Z = a) = P (Z = a
′) for all a and a′ such that
ιTa = ιTa′ where ι is the N-dimensional column vector with all elements equal to one.
Assumption 3 (Exclusion Restriction)
Y(Z,D) = Y(Z′,D) for all Z,Z′ and for all D.
Assumption 4 (Nonzero Average Causal Effect of Z on D)
The average causal effect of Z on D, E[Di(1)−Di(0)], is not equal to zero.
Assumption 5 (Monotonicity)
Di(1) ≥ Di(0) for all i. This implies the non-existence of defiers, or units that take the
treatment when not assigned to it and do not take the treatment when assigned to it.
2A fourth stratum, defiers, are those who take the treatment when not assigned to it but do not take the
treatment when assigned to it; however, identification of the LATE requires assuming the non-existence of
defiers.
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As shown by Angrist et al. (1996), given these assumptions, the potential outcomes for
Y can be reduced to Yi(Di), allowing definition of the causal effect of D on Y for unit i as
Yi(1)−Yi(0). Further the potential outcomes for D can be reduced to Di(Zi), allowing formal
definition of three principal strata. Compliers are individuals for whom Di(1)−Di(0) = 1.
In contrast, always-takers are individuals for whom Di(1) = Di(0) = 1, and never-takers are
individuals for whom Di(1) = Di(0) = 0.
The LATE, which will be denoted by τ , is then defined as the average causal effect of D
on Y for compliers:
τ = E[Yi(1)− Yi(0)|Di(1)−Di(0) = 1]
Under assumptions 1-5, Angrist et al. (1996) show that this estimand is also equivalent to
the ratio between the average causal effect of Z on Y (intent-to-treat effect), which will be
denoted by γ, and the average causal effect of Z on D (first-stage effect), which will be
denoted by pi and which is also equivalent to the compliance rate given the assumptions
above. That is:
τ =
γ
pi
γ = E[Yi(1, Di(1))− Yi(0, Di(0))]
pi = E[Di(1)−Di(0)] = P (Di(1)−Di(0) = 1)
As shown by Imbens and Angrist (1994), given these assumptions, the LATE can be
estimated consistently by the Wald IV estimator, which will be denoted by τˆ :
τˆ =
Ĉov(Yi, Zi)
Ĉov(Di, Zi)
where Yi, Di, and Zi correspond to the observed random variable values for unit i. In contrast
to other estimators of the LATE, such as those based on maximum likelihood estimation and
Bayesian methods (e.g. Imbens and Rubin, 1997), the Wald IV estimator is nonparametric
and does not require assumptions about the probability distributions underlying the data.
The Wald IV estimator is also the most accessible and commonly used estimator of the
LATE among applied researchers. The asymptotic variance of the estimator, as shown by
Imbens and Angrist (1994), is:
V τˆN =
E[2i {Zi − E[Zi]}2]
NCov2(Di, Zi)
where i = Yi − E[Yi]− τ(Di − E[Di]).
In the face of noncompliance, researchers often weigh the merits of focusing on the intent-
to-treat effect (ITT) vs. LATE as the ultimate estimand of interest from the perspective
of their own research goals and questions (e.g. Imbens, 2014a; Kitagawa, 2014; Swanson
and Herna´n, 2014; Imbens, 2014b). The ITT measures the average effect of treatment
assignment in the presence of noncompliance. This is an ideal estimand for researchers
wishing to understand the overall system-wide effect of introducing an intervention into the
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study context. However, the ITT does not capture a causal effect of the treatment itself. In
contrast, the LATE measures the average causal effect of the treatment for the compliers.
While the compliers are a subset of the underlying population, note that they are often the
sub-population of interest, as they are precisely the subset of individuals who can actually
be induced to take (or not take) the treatment. In contrast, it is often not relevant or useful
to understand the effect of a treatment for a sub-population who will never end up taking
the treatment (or who will always take it no matter what).
By measuring a causal effect of the treatment, the LATE thereby allows researchers to
understand the efficacy of the treatment itself. This can be a critical task for a number of
research goals. First, it allows for more direct scientific investigation of the underlying causal
phenomenon. Second, it facilitates efforts to improve the design of the intervention such that
it becomes more efficacious at the individual level. Third, it is also key for determining the
cost-efficiency of the treatment in many contexts. Given that costly interventions often
scale proportionately to the number of applications/dosages actually delivered, rather than
simply the number assigned, it is crucial to measure the cost-efficiency of delivered treatment
applications/dosages, which the LATE allows for but the ITT does not. In short, for studies
focused on understanding the efficacy of treatments and measuring their causal effects, the
LATE is often a more interesting, informative, and/or policy-relevant estimand.3
B. Proliferation of Parameters Affecting Power for the LATE
In general, we may separate power analysis parameters into three groups: error tolerance
parameters, investigation parameters, and distribution parameters. The error tolerance para-
meters are α (type-I error tolerance) and β (type-II error tolerance), where β is a parameter
only in the case where we are solving for a different parameter rather than calculating the
power (1−β). The investigation parameters are sample size and effect magnitude/size. These
are the parameters of fundamental economic interest that motivate the use of a pre-study
power analysis. Finally, the distribution parameters are the parameters that characterize
the distribution(s) of the population(s) of interest. In contrast to the tolerance parameters,
which are selected by convention or on a discretionary basis, and the investigation paramet-
ers, which the researcher seeks to learn about in order to make research design decisions, the
distribution parameters are matters of inconvenience. While they are (usually) not of strict
interest to the researcher, the distribution parameters have a dramatic impact on statistical
power, and they must be specified at values that are known or believed to reflect reality in
order for a power analysis to be properly calibrated and hence informative.
As described above, in the standard ATE context using absolute effect magnitudes, the
power formula requires specification of the variance of the ATE estimator. This variance
depends upon two distribution parameters: the potential outcome variances of both the
treatment and control conditions. In addition, by employing standardized effect sizes, these
3Recall, also, that in study designs that ensure the absence of always-takers (never-takers) the LATE becomes
the ATE for the treated (untreated).
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distribution parameters can be dispensed with. In the LATE context, a power formula would
also entail specifying the variance of the estimator. In contrast to the ATE context, however,
this variance depends upon many more distribution parameters in the LATE context. If we
consider the first-stage effect pi, which is the compliance rate and hence also the proportion
of compliers in the population, to be an investigation parameter in the LATE context,
then there are in fact nine distribution parameters that affect the variance of the Wald IV
estimator and hence also affect the power.
The reason for this proliferation of parameters has to do with heterogeneity across the
principal strata, which leads the estimator variance to be affected not only by the variances
of the three principal strata, but also their relative mean locations and their relative propor-
tions. The resulting distribution parameters are: (1) the complier control condition mean,
(2) the complier control condition variance, (3) the complier treatment condition variance,
(4) the never-taker (control) condition mean, (5) the never-taker (control) condition variance,
(6) the always-taker (treatment) condition mean, (7) the always-taker (treatment) condition
variance, (8) the proportion of never-takers, and (9) the proportion of always-takers.4 This
property is illustrated for the Wald IV estimator in the Supplementary Materials (SM) Ap-
pendix B (Tables B1-B2), which presents the results of a series of simulations illustrating the
power of the estimator as the distributional characteristics of the principal strata are varied.
C. Limitations of Existing Methods for Power Analysis
Given the expectation of noncompliance with treatment assignment, a researcher wishing to
perform a power analysis in order to inform the study design (e.g. number of subjects) has a
few existing options. However, the unique characteristics of the LATE context, namely the
existence of multiple principal strata characterized by distributional heterogeneity, signific-
antly limit the reliability of these existing methods.
The first existing option is to apply a standard power analysis to the ITT. However, for
researchers who intend to focus on and estimate the LATE, the problem with ITT power
analyses is that, for a given data-generating process, the power to detect non-zero effects
for the ITT difference-in-means estimator will deviate from that of estimators of the LATE,
as highlighted in previous work by Jo (2002). This phenomenon is illustrated in the SM
Appendix B (Table B3), which presents the results of simulations in which the power for
the LATE (Wald IV estimator) and ITT (difference-in-means estimator) change at different
rates as the simulation specifications are altered. In fact, as the simulations show, the
power for tests of the LATE may be higher or lower than the power for tests of the ITT
depending upon the distributional heterogeneity across the principal strata. This may seem
4It should be noted that the sum of (8), (9), and pi must be one, removing a degree of freedom in the
specification of distribution parameters. In addition, it should be noted that the treatment condition mean
for the compliers need not be specified since it is simply the sum of the compliers’ control condition mean
and the LATE, both of which are specified. Further, treatment (control) condition parameters need not be
specified for the never-takers (always-takers) because the treatment (control) condition never manifests in
the data for the never-takers (always-takers) by definition.
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surprising because the Wald IV estimator is simply a scaled version of the ITT, where the
ITT is divided by the compliance rate. However, the compliance rate is a quantity that
must also be estimated, and that estimate is generally correlated with the estimate of the
ITT, resulting in the Wald IV estimator having distinct statistical properties from the ITT
difference-in-means estimator.
To illustrate the problem more vividly, consider a hypothetical superpopulation whose
potential outcomes are depicted in Figure 1. Compliers comprise 30% of the superpopula-
tion, while always-takers and never-takers each comprise 35%. Note that compliance rates
of 0.3 and lower are prevalent in field experiments, encouragement-based RCTs, and nat-
ural experiments.5 The LATE has a value of 5 in the superpopulation displayed in Figure
1.6 In addition, the never-takers have a slightly higher mean potential outcome value (un-
der control) and always-takers have a slightly lower mean potential outcome value (under
treatment), consistent with a common scenario in which subjects with initially high out-
come levels have no incentive to take the treatment and subjects with low outcome values
are particularly motivated to access the treatment regardless of their assignment.7 10,000
samples of size 650 were randomly drawn from this superpopulation, and each unit had a
probability of 0.5 of being assigned to the treatment. Whether each unit actually took the
treatment was determined jointly by its treatment assignment and the principal stratum to
which it belonged. For each sample, hypothesis tests of a non-zero ITT and non-zero LATE
were performed using the difference-in-means and Wald IV estimators, respectively, thereby
allowing for a simulated comparison of the power of each test.8 The power for the ITT was
approximately 0.77, while the power for the LATE was substantially lower at 0.61. While
this is only a single hypothetical data-generating process, it conveys an important general
message: the results of an ITT power analysis can provide extremely inaccurate guidance
(e.g. a miscalibrated sample size recommendation) for researchers planning ultimately to
focus on and estimate the LATE. As a general rule, the mismatch between the power for the
ITT and power for the LATE will be more pronounced given a lower compliance rate and
greater distributional heterogeneity across the principal strata.
A second existing option is a scaled ATE power analysis, which is a commonly used
approach in which the results of a standard ATE power analysis are scaled by an appropriate
5For instance, the estimated compliance rate in a vote canvassing field experiment run by Gerber and
Green (2000) was around 0.3, the estimated compliance rate in an influenza vaccination encouragement
design evaluated by Hirano et al. (2000) was approximately 0.12, and in a natural experiment evaluated by
Angrist (1990) on the effect of Vietnam War veteran status on civilian earnings, the estimated compliance
rate (effect of draft eligibility on veteran status) ranged from 0.10 to 0.16 for white American citizens born
from 1950-1952.
6Specifically, the potential outcomes are normally distributed with a variance of 9 and means of 0 and 5 for
the compliers under control and under treatment, respectively.
7Specifically, the always-takers’ and never-takers’ potential outcomes are normally distributed with a variance
of 9 and means of -5 and 10, respectively. Note that only the treatment potential outcomes are relevant for
the always-takers, and only the control potential outcomes are relevant for the never-takers.
8The simulated power is the proportion of samples for which the test rejects the null hypothesis of no effect.
Two-sided hypothesis tests with α = 0.05 were used.
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Figure 1: Hypothetical Principal Strata Distributions
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function of the compliance rate. Using this approach, Duflo et al. (2007) present a formula for
computing minimum detectable effects in the presence of noncompliance based on a simple
scaling of the standard ATE formula, the result of which follows from the ATE estimator
variance being divided by the compliance rate squared. The rationale behind this process is
based on the fact that the Wald IV estimator is simply the ratio of the ITT to the compliance
rate. However, the scaled ATE power analysis treats the compliance rate as a fixed value
when, as already explained above, the compliance rate must be estimated and is generally
correlated with the ITT. The resulting problem with this approach, which Duflo et al. do
not make explicit but has been shown elsewhere (Baiocchi et al., 2014), is that a number of
strong and unrealistic assumptions are required for this scaling of the standard ATE power
analysis to yield the (approximately) correct results for the Wald IV estimator. Specifically,
it must be the case that (a) the never-takers have the same mean outcome value as the
untreated compliers, (b) the always-takers have the same mean outcome value as the treated
compliers, and (c) all groups have the same outcome variance. If any of those assumptions
are violated, the true power of the Wald IV estimator can diverge dramatically from the
power implied by this scaled ATE power analysis. SM Appendix B (Table B4) demonstrates
this result, illustrating how the scaled ATE power analysis, similar to an ITT power analysis,
can provide extremely unreliable guidance on power for the LATE.
Finally, as a third option, power analyses specifically for IV treatment effects have been
introduced in the epidemiology literature (Pierce et al., 2011; Freeman et al., 2013; Brion
et al., 2013; Jiang et al., 2015). In particular, Freeman et al. (2013), Brion et al. (2013), and
Jiang et al. (2015) all introduce power formulas for IV treatment effects. However, there are
two major limitations to the approaches taken by these studies. First, they require specifying
a number of variance components, about which a researcher may not have good preexisting
knowledge or priors. Second, they proceed from a classic IV perspective and hence neglect the
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extent to which these variance components depend upon the distinct distributional behavior
of the principal strata.
For instance, the formulas presented by Freeman et al. and Brion et al. both require
specifying V ar(Di).
9 This presents a challenge given noncompliance with the treatment
assignment, as V ar(Di) is a function of both the first stage effect pi (which is also the
compliance rate) and the proportion of always-takers versus never-takers. In other words, to
choose an informative value of V ar(Di), one must specify not only a hypothetical compliance
rate but also the precise pattern of noncompliance. In addition, Freeman et al. also require
specifying V ar(Yi|Di), while Brion et al. require specifying the biased asymptotic value of
the least squares estimator of the effect of D on Y . Finally, the approach taken by Jiang
et al. requires specifying the ITT, standard deviation of the potential outcome under control,
standard deviation of the error from regressing the treatment on the instrument, and the
correlation between the potential outcome under control and the error from regressing the
treatment on the instrument. In many study contexts in the social sciences, medicine, public
health, program evaluation, and other fields, the researcher will lack solid estimates or priors
on one or more of these parameters. In such contexts, the formulas offered by Freeman et al.,
Brion et al., and Jiang et al. cannot be used reliably.
D. General Complications for Designing LATE Power Analyses
As highlighted above, there are significant limitations and liabilities associated with existing
methods of power analysis in the presence of noncompliance. As a result, this is an area in
the applied methodological literature that requires new approaches and solutions. Yet there
are notable impediments to developing flexible and reliable approaches to power analysis in
the LATE context.
A first complication that has been recognized for some time relates to the local identifica-
tion of the LATE (Jo, 2002). As already described, the possibility of heterogeneous potential
outcome distributions across the three principal strata (compliers, never-takers, and always-
takers) combined with the possibility of different patterns of noncompliance leads to the
proliferation of parameters that affect power in the LATE context. Because these para-
meters jointly factor into the variance of LATE estimators, specifying a hypothetical value
for the estimator variance to enable a power analysis involves making explicit or implicit
assumptions about all of these parameters.
This first problem leads to a second complication in terms of being able to specify stand-
ardized effect sizes in such a way that the variance components of the power analysis drop
out. Whereas in the ATE context the fix is fairly simple and hence enables the analyst to
minimize the number of assumptions that must be made, such a fix has been elusive in the
LATE context. The result is that existing power analyses in the LATE context, whether ana-
lytic or simulation-based, have inconveniently required (explicit or implicit) distributional
9V ar(Di) enters both formulas directly as well as through the need to specify ρDZ (the correlation between
Di and Zi), which can only be mapped from a hypothetical first-stage effect pi by specifying both V ar(Di)
and V ar(Zi).
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assumptions that may not match the reality of the data that will eventually be collected.
IV. Introducing a Generalized Approach to Power Analysis for the LATE
The remainder of this paper introduces a new method of LATE power analysis that addresses
the problems described above and provides a more reliable tool than existing methods. The
innovation and contribution of this new method is in showing how, by employing effect
sizes, bounds can be placed on the power formula whereby neither variance components nor
patterns of heterogeneity and noncompliance need to be specified. Instead, in addition to
the effect size, sample size, and error tolerance parameters, the only other parameter that
must be specified by the researcher is the first-stage effect. In other words, only tolerance
and investigation parameters must be specified; the analyst need not specify nor even make
assumptions about the estimator variance or any of the underlying distribution parameters.
A. Deriving a Modified Power Formula
All of the results that follow pertain to estimating the LATE, and thus the standard LATE
assumptions (1-5) apply. Similar to the ATE context, the results also invoke the asymptotic
normality of the Wald IV estimator. Hence, the power formula begins as:
Φ
(
−c∗ + τ√
V τˆN
)
+ Φ
(
−c∗ − τ√
V τˆN
)
= 1− β
To begin, further assume that assignment to the treatment is randomized with equal prob-
ability of being assigned to the treatment and control conditions. (Note that this equal
assignment probability assumption will be relaxed later.)
Assumption 6 (Equal Assignment Probability)
P (Zi = 1) = 0.5
The LATE power analysis introduced in this paper proceeds by defining an effect size of
interest. Following conventional practice using effect sizes in ATE power analyses, the effect
size is defined in standardized terms with reference to the expected within-assignment-group
standard deviation of the outcome:
Definition 1: Define the effect size of interest as:
κ =
τ√
E[V ar(Yi|Zi)]
As will be discussed later, defining the effect size in this manner with reference to treat-
ment assignment groups is appealing for a number of reasons. In particular, it provides a
structure for determining reasonable effect sizes in advance of a study. In addition, it leads
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the resulting LATE power analysis derived below to nest the standard ATE power analysis
as a special case with full compliance. More discussion is provided in a later section.
By focusing on the effect size, κ takes the place of τ as one of the three investigation
parameters, along with pi and N . In order to derive a LATE power formula that does not
require specifying distribution parameters, or terms that depend on them, τ√
V τˆN
must be
expressed exclusively in terms of investigation parameters. Recall, however, the complexity
of the estimator variance: V τˆN =
E[2i {Zi−E[Zi]}2]
NCov2(Di,Zi)
where i = Yi−E[Yi]−τ(Di−E[Di]). Further
consider that given imperfect compliance in the LATE context, and hence selection into (or
out of) the treatment for some subjects,  is not an intrinsically meaningful disturbance. In
particular,  is not orthogonal to D and hence does not have a conditional expectation of 0;
by extension, E[2i ] is not a substantively meaningful term.
As a result of the distributional complexities in the LATE context, it is not possible to
derive a point calculation for the power of the Wald IV estimator without specifying its
variance or the underlying distribution parameters. However, given Assumption 6 (equal
assignment probability) and Definition 1, a set of tight bounds can be derived for the power
of the Wald IV estimator. Specifically, the following bounds can be put on τ√
V τˆN
:
Proposition 1: Given Assumption 6 (equal assignment probability) and Definition 1:
τ√
V τˆN
bounds :
√
0.25κ2Npi2
1 + κ2E[ν2i ]± 2κ
√
E[ν2i ]
where νi = Di − E[Di]− pi(Zi − E[Zi]).
Notably, this re-expression leaves only one remaining term that is not an investigation
parameter, E[ν2i ]. However, since D is binary, a practical and conservative re-expression of
E[ν2i ] can be undertaken by setting E[ν
2
i ] to its largest possible value as a function of pi. The
result is a final set of bounds on τ√
V τˆN
:
Proposition 2: Given Assumption 6 (equal assignment probability), and setting E[ν2i ] to
its largest possible value, the following bounds contain a tight lower bound and a slightly
conservative upper bound:
τ√
V τˆN
final bounds :
√
0.25κ2Npi2
1 + κ2(0.5− pi
2
)(0.5 + pi
2
)± 2κ√(0.5− pi
2
)(0.5 + pi
2
)
As can be seen, these final bounds contain only the three investigation parameters: κ,
pi, and N . Furthermore, the lower bound is tight—it cannot be raised without making
additional assumptions—thus providing a tight lower bound for the power.
The bounds in Proposition 2 can be plugged into the power formula Φ(−c∗+ τ/
√
V τˆN) +
Φ(−c∗ − τ/
√
V τˆN). Values of the investigation parameters κ, pi, and N—as well as a type-I
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error tolerance α to calculate c∗—can then be selected in order to calculate bounds on the
power, 1 − β, of the two-sided test of the hypothesis that the LATE is zero. Importantly,
there do not exist any variance terms in the modified power formula. As a result, it provides
bounds that capture any distributional patterns among all three principal strata. In other
words, the result is a generalized power analysis for the Wald IV estimator of the LATE
that is free of additional distributional assumptions and does not require specification of the
estimator variance or its underlying distribution parameters.
In addition, as with standard power analyses, the modified power formula can be re-
arranged to solve for the investigation parameters. Instead of calculating power based on
a specific effect size (κ), compliance rate (pi), and sample size (N), it can be more useful
to select a desired power level and solve for one of the other parameters by fixing the rest.
Of particular interest in this case should be κ, solving for which will yield the minimum
detectable effect size (MDES),10 and N , solving for which will yield the required sample size.
B. Solving for the Minimum Detectable Effect Size
Without loss of generality, assume τ > 0. Then, for reasonably high levels of power—which
includes conventional power levels, such as 0.8—the second term in the power formula is
negligible, simplifying the formula to:
Φ
(
−c∗ + τ√
V τˆN
)
= 1− β
Recalling that c∗ = Φ−1(1− α
2
) for a two-sided test, this can then be re-expressed as:
τ√
V τˆN
= Φ−1
(
1− α
2
)
+ Φ−1(1− β)
Let M = Φ−1(1− α
2
) + Φ−1(1− β), which is called the “multiplier.” As a result, the power
formula leads to:√
0.25κ2Npi2
1 + κ2(0.5− pi
2
)(0.5 + pi
2
)± 2κ√(0.5− pi
2
)(0.5 + pi
2
)
= M
κ can then be isolated such that the MDES can be computed as a function of the other
parameters. The resulting bounds on the MDES are as follows:
κLow =
2M
pi
√
N + 2M
√
(0.5− pi
2
)(0.5 + pi
2
)
κHigh =
2M
pi
√
N − 2M√(0.5− pi
2
)(0.5 + pi
2
)
κHigh represents the tight conservative bound.
10This term is borrowed from Bloom (2006), who used it in the ATE context as an extension of minimum
detectable effects measured in absolute terms (Bloom, 1995).
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C. Solving for the Sample Size
Instead of isolating κ as above, N can be isolated in order to solve for the required sample
size. Continuing to assume without loss of generality that τ > 0, the bounds on the required
sample size are:
NLow =
4M2
(
1 + κ2(0.5− pi
2
)(0.5 + pi
2
)− 2κ√(0.5− pi
2
)(0.5 + pi
2
)
)
κ2pi2
NHigh =
4M2
(
1 + κ2(0.5− pi
2
)(0.5 + pi
2
) + 2κ
√
(0.5− pi
2
)(0.5 + pi
2
)
)
κ2pi2
NHigh represents the tight conservative bound.
D. Narrowing the Bounds
By providing a strict lower bound on the power, the method presented above offers a discip-
lined and reliable means of performing a conservative power analysis for the LATE. However,
there is a tradeoff between conservatism and efficiency. If the lower bound is too conser-
vative, it will lead to underestimation of the power and hence overestimation of the MDES
and sample size required. This could then result in sub-optimal outcomes, such as a study
being over-funded to achieve the conservative sample size or perhaps not funded at all if the
sample size requirements exceed the financial resources available. As a result, it would be
useful to narrow the bounds on the power formula where possible.
Assuming without loss of generality that τ > 0, it can be shown that the bounds on the
power formula can be substantially narrowed when Y¯NT ≤ Y¯C ≤ Y¯AT , where Y¯C , Y¯NT , and
Y¯AT denote the expected observed outcome value for compliers, never-takers, and always-
takers (e.g. Y¯C = E[Yi|Complier]).
Assumption 7 (Ordered Means)
Y¯NT ≤ Y¯C ≤ Y¯AT
In the case of one-sided noncompliance, Assumption 7 (ordered means) can be simplified
to Y¯NT ≤ Y¯C or Y¯C ≤ Y¯AT , depending upon the direction of noncompliance. It should also be
noted that, in the case where noncompliance is almost one-sided (i.e. very few never-takers
or very few always-takers), the sparse principal stratum will have only a negligible impact
on estimation. Thus, as a practical matter, Assumption 7 can be simplified to Y¯NT ≤ Y¯C or
Y¯C ≤ Y¯AT as long as the sparse principal stratum is deemed sufficiently small.
As a result, if the researcher is comfortable making Assumption 7, then the lower bound
of the power formula can be raised and the following can be used for the power analysis:
Proposition 3: Given Assumption 7 (ordered means), the lower bound and hence conser-
vative power formula becomes:
Power∗ = Φ
(
−c∗ +
√
0.25κ2Npi2
1 + κ2(0.5− pi
2
)(0.5 + pi
2
)
)
+Φ
(
−c∗ −
√
0.25κ2Npi2
1 + κ2(0.5− pi
2
)(0.5 + pi
2
)
)
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By the same process described earlier, it is possible to solve for κ and N to derive an
alternative conservative MDES and required sample size, which leads to the following:
κ∗ =
2M√
Npi2 − 4M2(0.5− pi
2
)(0.5 + pi
2
)
N∗ =
4M2(1 + κ2(0.5− pi
2
)(0.5 + pi
2
))
κ2pi2
where again M = Φ−1(1− α
2
) + Φ−1(1− β).
When would Assumption 7 (ordered means) be reasonable? Roughly speaking, there
are two factors to consider when assessing the plausibility of this assumption. The first
relates to effect heterogeneity. Specifically, it should be the case that always-takers (never-
takers) select into (out of) the treatment because treatment uptake for them is associated
with effects that are larger (smaller) than the average treatment effect for the compliers,
or at least similarly sized. For instance, in the case of a positive and beneficial treatment,
we must expect the noncomplying study subjects to be sufficiently rational that they are
selecting into (out of) the treatment in anticipation of a particularly good (bad) effect on
their outcome. Alternatively, selection into and out of the treatment could also be made for
arbitrary reasons that are uncorrelated with individual effects. The second factor relates to
baseline outcome levels in the absence of the treatment. Specifically, we must expect that
always-takers (never-takers) do not have baseline outcome levels that are particularly low
(high) compared to that of the compliers.
Precisely when the assumption should be expected to hold, in light of the two factors
described above, will certainly be context dependent. However, specific research design steps
can be taken to increase its plausibility. First, studies can often be designed so as to exclude
one type of noncompliance. Indeed, many experiments are designed to prevent those not
assigned to the treatment from accessing it and thus ensuring the absence of always-takers.
By achieving one-sided noncompliance, the analyst need only consider two principal strata,
rather than three. The well-known National JTPA Study is one such example (Bloom et al.,
1997). In this experimental study, subjects were randomly assigned such that they were
either given an offer to enroll in a job training program (assigned to treatment) or excluded
from participating in the training for an 18-month period (assigned to control). However,
many subjects given access to the job training program decided not to receive the training,
resulting in a large chunk of never-takers. While there were some enterprising individuals
who gained access to the job training in spite of not being assigned to it, their numbers were
so small that there was virtually one-sided noncompliance.
Another research design step that can be taken is to impose reasonable restrictions on
the study population of interest to ensure more similar baseline outcome levels across the
principal strata. Again, the JTPA experiment is illustrative, as eligibility to participate in the
experiment was restricted to those with economic disadvantages and barriers to employment.
Had such restrictions not been made, the study may have included employed and/or higher
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income professionals who likely would have opted out of the job training program regardless
of treatment assignment, boosting the baseline economic outcome levels of the never-takers.
In fact, as shown in the SM Appendix C, the final results from the JTPA experiment
were consistent with the ordered means assumption in terms of an outcome variable that
measured the participants’ earnings in the 30-month period following their random assign-
ment. Appendix C also presents the results of two other studies that were consistent with the
ordered means assumption. One is a vote-canvassing field experiment (Gerber and Green,
2000). The other is a fuzzy regression discontinuity design on the effect of naturalization
on political integration (Hainmueller et al., 2016). That the ordered means assumption was
met in all three of these studies, which involved distinct study designs and research topics,
demonstrates the plausibility of this assumption in various research domains.
In contrast, however, another common scenario in field experiments and encouragement-
based RCTs is where subjects with initially high outcome levels have no incentive to take
the treatment and subjects with low outcome values are particularly motivated to access
the treatment regardless of their assignment. This pattern can lead to an ordering of the
principal strata means that is the opposite of the ordered means assumption, as illustrated
earlier in Figure 1. If the researcher believes such a scenario to be possible, the ordered
means assumption should not be applied, and the conservative lower bound on the power as
reflected by Proposition 2 should be used.
E. Discussion on Effect Sizes
As explained earlier, the effect size of interest in this paper (κ) is defined similarly to the way
effect sizes are conventionally defined in ATE power analyses, with reference to the expected
standard deviation of the outcome within treatment assignment groups. The difference, of
course, is that full compliance is assumed in the ATE case, and hence treatment assignment
is equivalent to treatment uptake. Nonetheless, the treatment assignment groups remain
conceptually and practically useful reference groups in the LATE case for several reasons.
First, the treatment assignment groups are the mathematically natural reference group,
allowing standard ATE power analysis results to nest as a special case within the LATE
power formula presented in this paper. Consider that in the special case of full compliance
(pi = 1), the LATE becomes the ATE. Further, given pi = 1, the LATE power bounds
presented in this paper, as laid out in Proposition 2, are simplified to a single value:
Power = Φ
(
−c∗ + κ
√
N
2
)
+ Φ
(
−c∗ − κ
√
N
2
)
Solving for the minimum detectable effect size and required sample size yields κ = 2M√
N
and
N = 4M
2
κ2
, where again M = Φ−1(1 − α
2
) + Φ−1(1 − β). These results are identical to the
conventional ATE power analysis results given asymptotic normality of the estimator and
equal probability of assignment to treatment and control (Cohen, 1988; Bloom, 2006).
Second, the treatment assignment groups contain a natural reference point for defining
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a standardized effect size. In particular, the distribution of the outcome under assignment
to control represents a natural state of the world in the absence of intervention, and hence
V ar(Yi|Zi = 0) is one of the few baseline values that can often be reliably measured or
estimated in advance of a study by analyzing data on the baseline population.11 Further,
while V ar(Yi|Zi = 1) cannot be measured in advance, it may be reasonable to assume it is
relatively close in value to V ar(Yi|Zi = 0). In such cases, E[V ar(Yi|Zi)] ≈ V ar(Yi|Zi = 0),
and hence the effect size of interest is defined (approximately) with reference to a naturally
occurring distribution that is measurable prior to study implementation.
Third, because V ar(Yi|Zi = 0) may be measurable or estimable in advance, this allows
for approximate mapping of effect sizes to absolute effects in the power formula. As long
as the researcher is comfortable assuming that V ar(Yi|Zi = 1) will not diverge substantially
from V ar(Yi|Zi = 0), then the researcher may estimate ωˆ0 = ̂
√
V ar(Yi|Zi = 0), use that
estimate as an approximate value for
√
E[V ar(Yi|Zi)], and hence replace κ with τωˆ0 . The
results presented above could then be modified to solve for a minimum detectable absolute
effect (i.e. solve for τ itself) or solve for the required sample size in terms of τ .
Irrespective of the availability of reliable estimates for ωˆ0, researchers may also determine
a target MDES by surveying previous studies and meta-analyses within their own fields of
study (e.g. Lipsey, 1990, Chapter 3). In his seminal presentation of the topic, Cohen (1988)
offered the conventional benchmarks in the social and behavioral sciences of 0.2, 0.5, and
0.8 as small, medium, and large effect sizes, respectively. These general conventions may be
useful as rough guidance. However, what is considered a small or large effect size inevitably
varies across disciplines and research topics. Accordingly, it is advisable for the researcher
to more carefully characterize the effect size scale within the research context at hand, in
consultation with relevant data from previous studies and meta-analyses, as is the case for
any power analysis irrespective of study design and compliance levels.
F. Comparing the Bounds to Simulations
To further validate the LATE power bounds derived in this paper, Figure 2 compares the
bounds to simulated power curves, where power is plotted as a function of κ. The solid
black lines denote the analytic upper and lower bounds, while the dashed black line de-
notes the alternative lower bound under Assumption 7 (ordered means). The colored lines
denote power curves that were simulated by specifying the full set of investigation and
distribution parameters, and hence simulating all three principal strata. For all of the
curves (analytic and simulated), the following parameters are fixed: pi = 0.5, N = 1500,
α = 0.05. In addition, for the simulated power curves, the following seven of the nine
distribution parameters are fixed: E[Yi(0)|Complier] = 0, V ar(Yi(0)|Complier) = 64,
V ar(Yi(1)|Complier) = 64, V ar(Yi(0)|NeverTaker) = 144, V ar(Yi(1)|AlwaysTaker) = 16,
P (NeverTaker) = 0.25, and P (AlwaysTaker) = 0.25. In contrast, the final two distri-
11In contrast, noncompliance leads to non-randomization of D, which means V ar(Yi|Di = 0) will not be
accurately reflected by pre-study estimates.
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bution parameters, E[Yi(0)|NeverTaker] and E[Yi(1)|AlwaysTaker], vary across the five
different simulation specifications shown in different colors. The five sets of values of
E[Yi(0)|NeverTaker] and E[Yi(1)|AlwaysTaker], starting with the first specification, are
as follows: (−20, 20), (−10, 10), (−3, 3), (10,−10), and (20,−20).12 This ensures that the
simulation includes specifications that both do and do not meet Assumption 7 (ordered
means), and hence allows for detailed evaluation of the bounds.
Figure 2: Simulated Power vs. Analytic Bounds
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Figure 2 provides a simple demonstration of the performance of the power bounds presen-
ted in this paper. As can be seen, the simulated curves fall within the analytic bounds de-
noted by the solid black lines. Furthermore, the alternative lower bound (the dashed black
line) also bounds the appropriate simulated curves. For specifications 1 and 2, Assump-
tion 7 (ordered means) is met by design at all values of κ, and hence the alternative lower
bound applies. Accordingly, the curves for these specifications all lie above the alternative
lower bound. In contrast, the ordered means assumption is violated by specifications 4 and
5. Thus, it is no surprise that the curves for these specifications lie below the alternative
lower bound. Additional graphical illustrations of the relationships between power and the
investigation parameters are provided in the SM Appendix D.
V. Relaxing the Equal Assignment Probability Assumption
In some situations, the researcher may have reason put an unequal probability on assignment
to the treatment and control conditions. For instance, treatment assignment/encouragement
12In these simulations, the underlying super populations were generated with normally distributed potential
outcomes with means and variances according to the specifications described here.
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may be costly. For such cases, it will be useful to relax Assumption 6.
A. Results with P (Zi = 1) = pz
In the IV-LATE literature, the simplifying homoskedasticity assumption is often made that
E[2i |Zi] = E[2i ]. While there may be few cases in which this assumption is likely to hold
exactly, it is often sufficiently reasonable such that it does not substantially affect statistical
inference. The assumption that E[2i |Z] = E[2i ] can be useful here.
Assumption 8 (Homoskedasticity)
E[2i |Zi] = E[2i ]
However, because the simplifying assumption that E[2i |Zi] = E[2i ] is not a conservative one,
it is useful to induce conservatism elsewhere. In order to do this, we can set E[ν2i ] = 0.25.
The following bounds on τ√
V τˆN
then follow without making Assumption 6 (equal assign-
ment probability):
Proposition 4: Given Assumption 8, E[ν2i ] = 0.25, and any value pz = P (Zi = 1):
τ√
V τˆN
relaxed bounds :
√
pz(1− pz)κ2Npi2
1 + 0.25κ2 ± κ
As before, to derive bounds on the power, the bounds above can simply be plugged into
the power formula Φ(−c∗+ τ/
√
V τˆN) + Φ(−c∗− τ/
√
V τˆN). Again, κ can also be isolated such
that the MDES can be computed as a function of the other parameters. Assuming without
loss of generality that τ > 0, the resulting bounds on the MDES are as follows:
κLow =
2M
2pi
√
Npz(1− pz) +M
κHigh =
2M
2pi
√
Npz(1− pz)−M
where again M = Φ−1
(
1− α
2
)
+ Φ−1 (1− β), and κHigh represents the conservative bound.
N can also be isolated to solve for the required sample size. Continuing to assume without
loss of generality that τ > 0, the resulting bounds on the sample size are as follows:
NLow =
M2(1 + 0.25κ2 − κ)
pz(1− pz)κ2pi2
NHigh =
M2(1 + 0.25κ2 + κ)
pz(1− pz)κ2pi2
NHigh represents the conservative bound.
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B. Narrowing the Bounds while Relaxing the Equal Assignment Probability Assumption
As before, the lower bound of the power can be increased under Assumption 7 (ordered
means). The result is the following alternative lower bound.
Proposition 5: Given Assumption 8, E[ν2i ] = 0.25, any value pz = P (Zi = 1), and Assump-
tion 7 (ordered means), the lower bound and hence conservative power formula becomes:
Power∗ = Φ
(
−c∗ +
√
pz(1− pz)κ2Npi2
1 + 0.25κ2
)
+ Φ
(
−c∗ −
√
pz(1− pz)κ2Npi2
1 + 0.25κ2
)
Solving for κ and N to derive an alternative conservative MDES and required sample
size leads to the following:
κ∗ =
2M√
4pi2Npz(1− pz)−M2
N∗ =
M2(1 + 0.25κ2)
pz(1− pz)κ2pi2
where again M = Φ−1(1− α
2
) + Φ−1(1− β)
Appendix E in the SM presents results comparing simulated power curves to the analytic
bounds given P (Zi = 1) = 0.25, similar to the results shown earlier in Figure 2. Appendix
E demonstrates that the analytic bounds derived for the general case where P (Zi = 1) = pz
perform as well as the bounds derived for the special case of P (Zi = 1) = 0.5.
VI. The Method in Context
To illustrate how the method of LATE power analysis presented in this paper could be used,
this section applies it to the context of the National JTPA Study (Bloom et al., 1997). As
described earlier, subjects were randomly assigned such that they were either allowed to
enroll in a job training program (assigned to treatment) or excluded from the training for an
18-month period (assigned to control). However, many subjects exhibited noncompliance:
many assigned to the treatment decided not to enroll in the training program, while a few
assigned to the control gained access to the job training program. The outcome of interest
here is the subjects’ earnings in the 30-month period following their random assignment.
For the purposes of this illustration, two different values of pi will be employed. The
first is its estimated value as observed in the JTPA data,13 which is 0.63. This is, of course,
not necessarily something the researcher would know precisely in advance, but it provides
a useful point of reference. The second value for pi will be 0.4, which we may view as a
researcher’s conservative guess prior to the actual study. We will fix pz at its observed value
of 0.67, since this is a value over which the researcher has control, and set α and β at
13The dataset used here is the tabulation of the JTPA study data by Abadie et al. (2002). The data
correspond to adult participants in the JTPA experiment for whom 30-month earnings were measured.
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their conventional levels of 0.05 and 0.2, respectively. We can then specify a range of effect
sizes (κ’s) to determine the bounds on the sample size required under these specifications.
Furthermore, because we know in retrospect the pooled within-assignment-group variance
of the outcome (earnings), we can map the κ values to absolute effect values (τ ’s). Note also
that in the JTPA experiment this value is virtually identical to V̂ ar(Yi|Zi = 0), which could
have been estimated in advance of the study via a baseline survey given that assignment to
control represents a natural state of the world in the absence of intervention.14 As a result,
the κ values could have been mapped to τ values in the absence of retrospective data, to the
benefit of implementing the power analysis.
The results given pi = 0.63 are shown in Table 1, with the conservative N corresponding
to the power lower bound, and the alternative N corresponding to the alternative power lower
bound under Assumption 7 (ordered means). For instance, given a desired effect size of 0.1,
the conservative sample size recommendation would be approximately 10, 000 observations
to achieve a power level of 0.8, while the alternative sample size given Assumption 7 would
be approximately 9, 000 observations. The actual LATE effect size estimate in the pooled
adult sample was 0.11.15 Thus, it is no surprise that given the actual sample size of 11, 204
adult participants and the fact that the ordered means assumption was ultimately met in this
study, the estimated LATE is statistically significant (p < 0.001). While 0.11 would generally
be considered a relatively small effect size—according to the rough guidance presented by
Cohen (1988), 0.2, 0.5, and 0.8 are benchmarks for small, medium, and large effect sizes
in the social and behavioral sciences—the JTPA study was fortunately of sufficiently large
scale to detect this effect in the pooled adult sample.
Table 1: LATE Power Analysis, Given pi = 0.63 and pZ = 0.67
κ τ Conservative N from Alternative N from
LATE Power Analysis LATE Power Analysis
0.05 837.94 37588 35799
0.10 1675.89 9861 8966
0.15 2513.83 4594 3998
0.20 3351.78 2706 2258
0.25 4189.72 1811 1453
0.30 5027.66 1314 1016
0.35 5865.61 1008 752
0.40 6703.55 805 581
0.45 7541.50 663 464
0.50 8379.44 559 380
Table 2 displays the results given pi = 0.4. As shown, an increase in the amount of
noncompliance leads to a disproportionately large increase in the sample size requirements.
14 ̂√E[V ar(Yi|Zi)] = 16759, while V̂ ar(Yi|Zi = 0) = 16180, a difference of about 3%.
15The estimate of the local average treatment effect of the training program on earnings is $1, 849. This
divided by the expected within-assignment-group standard deviation of earnings in the sample, 16, 759,
yields an effect size of 0.11.
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While noncompliance is assumed to increase by a factor of about 1.6, the required sample
size given any particular κ under both bounds increases by a factor of about 2.5. As these
results show, had the compliance rate pi actually been 0.4, it is likely that the JTPA study
would have failed to find a statistically significant local effect of the training program on
earnings, even in the pooled adult sample. The method of LATE power analysis presented
in this paper is designed to alert researchers to such possibilities of under-powered designs
before studies are launched without requiring researchers to make the collection of strong
assumptions involved in other approaches to LATE power analysis.
Table 2: LATE Power Analysis, Given pi = 0.4 and pZ = 0.67
κ τ Conservative N from Alternative N from
LATE Power Analysis LATE Power Analysis
0.05 837.94 93241 88804
0.10 1675.89 24461 22242
0.15 2513.83 11395 9916
0.20 3351.78 6712 5602
0.25 4189.72 4493 3605
0.30 5027.66 3260 2521
0.35 5865.61 2501 1867
0.40 6703.55 1997 1442
0.45 7541.50 1644 1151
0.50 8379.44 1387 943
VII. Power with Covariates
The standard LATE assumptions establish the consistency of the Wald IV estimator without
covariate adjustment, but covariates can still be used to improve the precision of the estim-
ates. As a result, researchers sometimes employ covariate adjustment in order to attain a
more powerful LATE estimator. A common approach is to use linear two-stage least squares
(2SLS), which is equivalent to modeling and estimating linear first-stage and intent-to-treat
relationships (Angrist and Pischke, 2009, pp. 120-122):
Di = Wiη + piZi + ν
∗
i (1)
Yi = Wiξ + γZi + ζ
∗
i (2)
where Wi corresponds to a set of covariates, as well as an intercept. Provided that the
covariates contained in Wi are pre-treatment-assignment covariates—that is, they are inde-
pendent of Zi and hence do not result in biased estimates of pi and γ—then the LATE can
be estimated consistently by γˆ
pˆi
, where γˆ and pˆi are the linear least squares estimators. In
addition, if W helps to explain variation in D and/or Y that is left unexplained by Z, then
the covariate adjustment can also decrease the variance of γˆ
pˆi
. As a result, linear 2SLS with
covariate adjustment has the potential to offer a more powerful estimator of the LATE, and
the method presented in this paper can be extended to incorporate these gains.
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Definition 2: Define the following:
R2DW =
σ2 − σ∗2
σ2
and R2YW =
ω2 − ω∗2
ω2
where σ2 = E[ν2i ] as defined in the proof of Proposition 1, ω
2 = E[ζ2i ] as defined in the proof
of Proposition 1, σ∗2 = E[ν∗2i ] from equation (1), and ω
∗2 = E[ζ∗2i ] from equation (2).
R2DW measures the proportion of variation in D left unexplained by Z that is explained
by the covariates contained in W, while R2YW measures the proportion of variation in Y left
unexplained by Z that is explained by the covariates contained in W. Given Definition 2,
covariate adjustment in the 2SLS framework can be employed to yield the following bounds
for use in the power formula:
τ√
V 2̂SLSN
bounds :
√
0.25κ2Npi2
(1−R2YW ) + κ2(1−R2DW )E[ν2i ]± 2κ
√
(1−R2YW )(1−R2DW )E[ν2i ]
As previously, this formula can be modified to both relax Assumption 6 (equal assignment
probability) and employ Assumption 7 (ordered means), and E[ν2i ] replaced with either
(0.5 − pi
2
)(0.5 + pi
2
) or 0.25 depending on whether Assumption 6 is made. More detail is
provided in the SM Appendix F. It must be emphasized that the results described in this
section only apply given the standard LATE assumptions (1-5) as well as independence
between Z and W. In other words, the assumptions necessary for the consistency of the
estimator must be met without covariate adjustment, the purpose of covariate adjustment
must simply be to decrease the variance of the estimator, and the covariates must not be
affected by Z.
VIII. Power with Variable Treatments
In cases where the endogenous treatment is no longer binary but rather has variable intensity
(e.g. drug dosage, years of schooling), Angrist and Imbens (1995) have shown that the Wald
IV estimator can still be used under Assumptions 1-5. In this case, however, the Wald IV
estimator is consistent for a new estimand they call the average causal response (ACR),
which is “a weighted average of causal responses to a unit change in treatment, for those
whose treatment status is affected by the instrument” (p. 435). In other words, like with the
LATE, the estimand only pertains to those subjects for whom the instrument has a non-zero
effect on treatment uptake/dosage, but the ACR is a weighted average rather than a simple
average of the individual-level causal effects of the treatment on the outcome.16
In spite of the modified estimand, the general properties of the Wald estimator, including
its variance, remain the same. Furthermore, the assumption of a binary treatment is not crit-
ical in the derivation of the power formulas introduced in this paper. The binary treatment
16See Angrist and Imbens (1995) for more details on the weighting formula.
23
assumption was employed in determining values for E[ν2i ], but a linear re-scaling of a multi-
valued treatment to the interval [0, 1] would mean the conservative value of E[ν2i ] = 0.25
would remain valid. As arbitrary linear transformations of variables do not affect statistical
power, the method of power analysis presented in this paper can also be applied to vari-
able treatments.17 Yet the researcher must keep in mind that given a variable treatment,
the estimand that is identified is the ACR rather than the LATE, and pi can no longer be
interpreted simply as the compliance rate.
IX. Conclusion
This paper proposed a new approach to power analysis in the LATE context that makes
three important contributions. First, in contrast to previous approaches, it does not involve
distributional assumptions about the various principal strata. Second, and most importantly,
it provides a tight lower bound on the power while removing the need to specify or make
assumptions about variance components or distributional heterogeneity across the principal
strata. Third, it shows how additional assumptions can be made to raise the lower bound
to better balance conservatism with efficiency.
By providing bounds on the power that are free of distributional assumptions, this paper
introduces a reliable and disciplined way of computing power conservatively without the
inefficiencies of other approaches (e.g. setting arbitrarily high variances) that can lead to ex-
cessively conservative calculations. The result is a generalized approach to power analysis in
the LATE context that is simultaneously conservative, disciplined, and simple to implement.
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Appendix A: Proofs
Proof of Proposition 1.
To begin, the variance of the estimator, V τˆN =
E[2i {Zi−E[Zi]}2]
NCov2(Di,Zi)
, can be simplified as follows:
Lemma 1: Given Assumption 6 (equal assignment probability),18
V τˆN =
E[2i ]
0.25Npi2
where i = Yi − E[Yi]− τ(Di − E[Di]).
Now, let ζi = Yi − E[Yi] − γ(Zi − E[Zi]) and νi = Di − E[Di] − pi(Zi − E[Zi]). The
variance of the estimator can then be re-expressed as follows:
Lemma 2: Given Assumption 6 (equal assignment probability),
V τˆN =
E[ζ2i ] + τ
2E[ν2i ]− 2τE[ζiνi]
0.25Npi2
where ζi = Yi − E[Yi]− γ(Zi − E[Zi]) and νi = Di − E[Di]− pi(Zi − E[Zi]).
The value and even sign of E[ζiνi] cannot be known without making additional assump-
tions. However, E[ζiνi] can be eliminated by employing the following strict bounds:
Lemma 3: Assuming without loss of generality that τ > 0,
E[ζ2i ] + τ
2E[ν2i ]− 2τ
√
E[ν2i ]
√
E[ζ2i ]
0.25Npi2
≤ V τˆN ≤
E[ζ2i ] + τ
2E[ν2i ] + 2τ
√
E[ν2i ]
√
E[ζ2i ]
0.25Npi2
18Proofs of all lemmas can be found below.
i
Hence, we have the following bounds for V τˆN :
V τˆN bounds :
E[ζ2i ] + τ
2E[ν2i ]± 2τ
√
E[ν2i ]
√
E[ζ2i ]
0.25Npi2
As established by Definition 1, let κ = τ√
E[V ar(Yi|Zi)]
. It is then possible re-express τ as
follows:
Lemma 4: Given Definition 1,
τ = κ
√
E[ζ2i ]
Now, for convenience, work with the square of τ√
V τˆN
. Given Assumption 6 (equal assign-
ment probability), Definition 1, and Lemmas 1-4:
τ 2
V τˆN
=
0.25κ2E[ζ2i ]Npi
2
E[ζ2i ] + τ
2E[ν2i ]± 2τ
√
E[ζ2i ]
√
E[ν2i ]
=
0.25κ2E[ζ2i ]Npi
2
E[ζ2i ] + κ
2E[ζ2i ]E[ν
2
i ]± 2κE[ζ2i ]
√
E[ν2i ]
=
0.25κ2Npi2
1 + κ2E[ν2i ]± 2κ
√
E[ν2i ]
Notably, E[ζ2i ] can be factored out of both the numerator and denominator and hence
canceled out. This yields the following tight bounds on τ√
V τˆN
:
τ√
V τˆN
bounds :
√
0.25κ2Npi2
1 + κ2E[ν2i ]± 2κ
√
E[ν2i ]

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Proof of Lemma 1.
The asymptotic variance of the Wald IV estimator, as shown by Imbens and Angrist
(1994), is:
V τˆN =
E[2i {Zi − E[Zi]}2]
NCov2(Di, Zi)
where i = Yi − E[Yi]− τ(Di − E[Di]).
Given Assumption 6 (equal assignment probability):
E[2i {Zi − E[Zi]}2] = E[2i {Zi − 0.5}2] = E[E[2i {Zi − 0.5}2|Zi]]
= p(Zi = 0)E[
2
i {0− 0.5}2|Zi = 0] + p(Zi = 1)E[2i {1− 0.5}2|Zi = 1]
= 0.5E[2i 0.25|Zi = 0] + 0.5E[2i 0.25|Zi = 1]
= {0.5E[2i |Zi = 0] + 0.5E[2i |Zi = 1]}0.25
= E[2i ]0.25
Thus,
V τˆN =
E[2i {Zi − E[Zi]}2]
NCov2(Di, Zi)
=
E[2i ]V ar(Zi)
NCov2(Di, Zi)
Further, this can be re-expressed as:
V τˆN =
E[2i ]
N
V ar(Zi)
Cov2(Di, Zi)
V ar(Zi)
V ar(Zi)
=
E[2i ]
N
V ar(Zi)
Cov(Di, Zi)
V ar(Zi)
Cov(Di, Zi)
1
V ar(Zi)
Finally, since Cov(Di,Zi)
V ar(Zi)
= pi and V ar(Zi) = 0.25, this further simplifies to:
V τˆN =
E[2i ]
0.25Npi2

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Proof of Lemma 2.
Let ζi = Yi − E[Yi] − γ(Zi − E[Zi]) and νi = Di − E[Di] − pi(Zi − E[Zi]). Given
i = Yi − E[Yi]− τ(Di − E[Di]) and γpi = τ under Assumptions 1-5, the following holds:
i = ζi − τνi
Hence,
E[2i ] = E[(ζi − τνi)2] = E[ζ2i ] + τ 2E[ν2i ]− 2τE[νiζi]
Combined with Lemma 1, this results in:
V τˆN =
E[ζ2i ] + τ
2E[ν2i ]− 2τE[ζiνi]
0.25Npi2

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Proof of Lemma 3.
Given E[ζi] = E[νi] = 0, E[ζiνi] = Cov(ζi, νi). By the Cauchy-Schwarz inequality, E[ζiνi]
is then bounded as follows:
−
√
E[ζ2i ]E[ν
2
i ] = −
√
V ar(νi)V ar(ζi) ≤ E[ζiνi] = Cov(νi, ζi)
≤
√
V ar(νi)V ar(ζi) =
√
E[ζ2i ]E[ν
2
i ]
Hence, assuming without loss of generality that τ > 0, it is conservative to set E[ζiνi] to
its lower-bound value (thereby setting −2τE[ζiνi] to its upper-bound value):
E[ζ2i ] + τ
2E[ν2i ]− 2τE[ζiνi] ≡ E[ζ2i ] + τ 2E[ν2i ]− 2τ(−
√
E[ζ2i ]E[ν
2
i ])
= E[ζ2i ] + τ
2E[ν2i ] + 2τ
√
E[ζ2i ]E[ν
2
i ]
As a result, this component in the denominator of τ
V τˆN
is set to its largest possible value,
making τ
V τˆN
as small as possible. This will yield a tight lower bound on the power formula. A
tight upper bound on the power can also be computed by setting E[ζiνi] to its upper-bound
value. 
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Proof of Lemma 4.
Given ζi = Yi−E[Yi]−γ(Zi−E[Zi]), we have that Yi = ζi+E[Yi]+γ(Zi−E[Zi]). Hence,
V ar(Yi|Zi) = V ar(ζi + E[Yi] + γ(Zi − E[Zi])|Zi) = V ar(ζi|Zi)
As a result,
E[V ar(Yi|Zi)] = E[V ar(ζi|Zi)] = V ar(ζi)− V ar(E[ζi|Zi])
by the law of total variance. Further, since γ = E[Yi|Zi = 1]− E[Yi|Zi = 0] by assumptions
1-5, it can be shown that E[ζi|Zi] = E[ζi|Zi = 0] = E[ζi|Zi = 1] = 0. For E[ζi|Zi = 0]:
E[ζi|Zi = 0] = E[Yi − E[Yi]− γ(Zi − E[Zi])|Zi = 0] = E[Yi|Zi = 0]− E[Yi] + γE[Zi]
= E[Yi|Zi = 0]− {E[Yi|Zi = 0](1− E[Zi]) + E[Yi|Zi = 1]E[Zi]}
+{E[Yi|Zi = 1]E[Zi]− E[Yi|Zi = 0]E[Zi]}
= 0
and the result follows similarly for E[ζi|Zi = 1]. As a result,
E[V ar(Yi|Zi)] = E[V ar(ζi|Zi)] = V ar(ζi)− V ar(E[ζi|Zi]) = V ar(ζi) = E[ζ2i ]
and hence
τ = κ
√
E[ζ2i ]

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Proof of Proposition 2.
First, the following can be shown.
Lemma 5:
E[ν2i ] ≤
(
0.5− pi
2
)(
0.5 +
pi
2
)
Then, simply substitute (0.5− pi
2
)(0.5 + pi
2
) in for E[ν2i ] in the result in Proposition 1. 
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Proof of Lemma 5.
Consider that, by Assumption 6 (equal assignment probability):
E[ν2i ] = E[V ar(Di|Zi)] = 0.5V ar(Di|Zi = 0) + 0.5V ar(Di|Zi = 1)
= 0.5[V ar(Di|Zi = 0) + V ar(Di|Zi = 1)]
Thus, E[ν2i ] is maximized by maximizing V ar(Di|Zi = 0) + V ar(Di|Zi = 1).
Further, consider that D is binary with E[Di|Zi = 1] = E[Di|Zi = 0] + pi. As a result,
V ar(Di|Zi = 0) + V ar(Di|Zi = 1) is maximized when E[Di|Zi = 1] and E[Di|Zi = 0] are
equidistant from 0.5. This occurs when E[Di|Zi = 0] = 0.5− pi2 and E[Di|Zi = 0] = 0.5 + pi2 .
The result is the following upper-bound value:
E[ν2i ] = E[V ar(Di|Zi)] = 0.5V ar(Di|Zi = 0) + 0.5V ar(Di|Zi = 1)
= 0.5
(
0.5− pi
2
)(
0.5 +
pi
2
)
+ 0.5
(
0.5 +
pi
2
)(
0.5− pi
2
)
=
(
0.5− pi
2
)(
0.5 +
pi
2
)

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Proof of Proposition 3.
As described above, the power formula bounds were based on the bounds of E[νiζi] =
Cov(νi, ζi). Thus, it is possible to narrow the power bounds, specifically to increase the lower
bound, if it is the case that Cov(νi, ζi) ≥ 0. Assuming without loss of generality that τ > 0,
it can be shown that this condition is met when Y¯NT ≤ Y¯C ≤ Y¯AT , where Y¯C , Y¯NT , and Y¯AT
denote the expected observed outcome value for compliers, never-takers, and always-takers
(e.g. Y¯C = E[Yi|Complier]).
Lemma 6: Letting Xi denote the principal stratum to which unit i belongs and assuming
without loss of generality that τ > 0,
Cov(E[Di|Xi], E[Yi|Xi]) ≥ 0 =⇒ Cov(νi, ζi) ≥ 0
∴ Y¯NT ≤ Y¯C ≤ Y¯AT =⇒ Cov(νi, ζi) ≥ 0
In the case of one-sided noncompliance, the missing principal stratum will not factor
into Cov(E[Di|Xi], E[Yi|Xi]). This simplifies Assumption 7 (ordered means assumption) to
Y¯NT ≤ Y¯C or Y¯C ≤ Y¯AT , depending upon the direction of noncompliance. It should also be
noted that, in the case where noncompliance is almost one-sided (i.e. very few never-takers
or very few always-takers), the sparse principal stratum will have only a negligible impact
on Cov(E[Di|Xi], E[Yi|Xi]). Thus, as a practical matter, the ordered means assumption can
be simplified to Y¯NT ≤ Y¯C or Y¯C ≤ Y¯AT as long as the sparse principal stratum is deemed
sufficiently small.
As a result, if Assumption 7 is made, then Cov(νi, ζi) is non-negative and hence it is
possible to set Cov(νi, ζi) = 0 for the lower bound of the power calculation. By Lemma 6,
Y¯NT ≤ Y¯C ≤ Y¯AT =⇒ Cov(νi, ζi) ≥ 0. The value that produces the most conservative (i.e.
lowest) power calculation is Cov(νi, ζi) = 0. Given Cov(νi, ζi) = 0,
τ 2
V τˆN
=
0.25κ2Npi2
1 + κ2E[ν2i ]
Finally, since D is binary, E[ν2i ] can be simplified as a function of pi, with E[ν
2
i ] =
(0.5− pi
2
)(0.5 + pi
2
) being the most conservative possibility by Lemma 5.
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The result, then, is that:
τ√
V τˆN
=
√
0.25κ2Npi2
1 + κ2(0.5− pi
2
)(0.5 + pi
2
)
Hence, the lower bound for the power becomes:
Power∗ = Φ
(
−c∗ +
√
0.25κ2Npi2
1 + κ2(0.5− pi
2
)(0.5 + pi
2
)
)
+Φ
(
−c∗ −
√
0.25κ2Npi2
1 + κ2(0.5− pi
2
)(0.5 + pi
2
)
)

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Proof of Lemma 6.
Recall that:
νi = Di − E[Di]− pi(Zi + E[Zi])
ζi = Yi − E[Yi]− γ(Zi + E[Zi])
Hence
Cov(νi, ζi) = Cov(Di − piZi, Yi − γZi)
= Cov(Di, Yi)− piCov(Zi, Yi)− γCov(Di, Zi) + piγV ar(Zi)
= Cov(Di, Yi)− piCov(Zi, Yi)− γCov(Di, Zi) + Cov(Di, Zi)
V ar(Zi)
γV ar(Zi)
= Cov(Di, Yi)− piCov(Zi, Yi)
It is further possible to decompose Cov(Di, Yi) using the law of total covariance, condi-
tioning on principal strata. Let Xi denote the principal stratum to which unit i belongs,
making the usual assumption of no defiers. Continue to assume that P (Zi = 1) = 0.5, and
WLOG that τ > 0. Let Y¯C , Y¯NT , and Y¯AT denote the expected observed outcome value for
compliers, never-takers, and always-takers (e.g. Y¯C = E[Yi|Complier]). Then,
Cov(Di, Yi) = E[Cov(Di, Yi|Xi)] + Cov(E[Di|Xi], E[Yi|Xi])
= P (Complier)Cov(Di, Yi|Complier) + Cov(E[Di|Xi], E[Yi|Xi])
since Cov(Di, Yi|AlwaysTaker) = Cov(Di, Yi|NeverTaker) = 0.
Furthermore, we can show that:
P (Complier)Cov(Di, Yi|Complier) = P (Complier)Cov(Zi, Yi|Complier)
= pi
Cov(Zi, Yi|Complier)
V ar(Zi|Complier) V ar(Zi|Complier)
= pi
Cov(Di, Yi|Complier)
V ar(Di|Complier) V ar(Zi)
= piτV ar(Zi)
= γV ar(Zi)
=
Cov(Zi, Yi)
V ar(Zi)
V ar(Zi)
= Cov(Zi, Yi)
xi
This means that:
Cov(νi, ζi) = Cov(Di, Yi)− piCov(Zi, Yi)
= Cov(Zi, Yi) + Cov(E[Di|Xi], E[Yi|Xi])− piCov(Zi, Yi)
= (1− pi)Cov(Zi, Yi) + Cov(E[Di|Xi], E[Yi|Xi])
The first term (1 − pi)Cov(Zi, Yi) is non-negative by the assumption (WLOG) that τ >
0. Hence, Cov(νi, ζi) is guaranteed to be non-negative if Cov(E[Di|Xi], E[Yi|Xi]) is non-
negative, which is true when Y¯NT ≤ Y¯C ≤ Y¯AT . 
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Proof of Proposition 4.
Given E[2i |Zi] = E[2i ], then regardless of the value of P (Zi = 1), the following holds:
V τˆN =
E[2i {Zi − E[Zi]}2]
NCov2(Di, Zi)
=
E[2i ]V ar(Zi)
NCov2(Di, Zi)
As a result, Assumption 6 (equal assignment probability) is no longer necessary, as it
previously was in Lemma 1. Lemmas 1-6 and Propositions 1-3 then proceed as before with
two exceptions. First, whereas previously V ar(Zi) = 0.25, now V ar(Zi) = pz(1− pz), where
pz = P (Zi = 1). Hence, V
τˆ
N =
E[2i ]
pz(1−pz)Npi2 . Second, because the simplifying assumption that
E[2i |Zi] = E[2i ] is not a conservative one, it will be useful to induce conservatism elsewhere.
In order to do this, we can set E[ν2i ] = 0.25. This is conservative because D is binary, which
means its maximum marginal variance is 0.25, a value that its conditional variance (E[ν2i ])
cannot exceed. 
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Proof of Proposition 5.
The proof follows from the results of Lemma 6 applied to Proposition 4. 
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Appendix B: LATE Power Simulations
This appendix presents the results of a series of simulations illustrating the power of the
Wald IV estimator of the LATE as the distributional characteristics of the principal strata
are varied.
Table B1: LATE Power Simulations, Varying the Investigation Parameters
Fixed Parameters: Varying Parameter Power
τ = 5, pi = 0.2, N =
E[YC(0)] = 0, SD(YC(0)) = 8, SD(YC(1)) = 8, 1000 0.43
p˙iNT = 0.4, E[YNT (0)] = −3, SD(YNT (0)) = 12, 2000 0.71
p˙iAT = 0.4, E[YAT (1)] = 3, SD(YAT (1)) = 4 4000 0.93
N = 1000, pi = 0.2, τ =
E[YC(0)] = 0, SD(YC(0)) = 8, SD(YC(1)) = 8, 5 0.43
p˙iNT = 0.4, E[YNT (0)] = −3, SD(YNT (0)) = 12, 6 0.57
p˙iAT = 0.4, E[YAT (1)] = 3, SD(YAT (1)) = 4 7 0.68
In the simulations presented, α is held fixed at 0.05. The sample size N , LATE τ , and
first-stage effect pi are specified, and samples are generated with specified proportions of
compliers (pi), never-takers (p˙iNT ), and always-takers (p˙iAT ). For the compliers, a control
condition potential outcome mean E[YC(0)] is specified (the treatment condition potential
outcome mean is determined by the specified τ), as are control condition and treatment
condition potential outcome standard deviations SD(YC(0)) and SD(YC(1)), with poten-
tial outcome values being randomly generated to be normally distributed. The potential
outcome distributions of the never-takers and always-takers are also randomly generated to
be normally distributed; for the never-takers, only a control condition mean and variance,
E[YNT (0)] and SD(YNT (0)), must be specified, and for the always-takers, only a treatment
condition mean and variance, E[YAT (1)] and SD(YAT (1)), must be specified. Finally, the
treatment is randomly assigned with probability one half. However, whether a unit is actu-
ally treated, and hence obtains an observed outcome value that is the treatment (or control)
condition potential outcome, is determined not only by treatment assignment but also the
principal stratum to which that unit belongs.
A variety of specifications are presented in Tables B1 and B2, with specific parameters
being varied as others are held constant to demonstrate the impact on the power of the test.
For each specification, 5, 000 samples are simulated, and for each simulation, a test of the
hypothesis of a non-zero LATE is undertaken using the Wald IV estimator. This allows for
a simulated power to be computed by calculating the proportion of the 5, 000 simulations
for which it is possible to reject the null hypothesis that τ = 0 given a two-tailed test with a
type-I error tolerance of α = 0.05. The results shown in Tables B1 and B2 demonstrate that,
in addition to the investigation parameters, all nine of the distribution parameters have an
xv
Table B2: LATE Power Simulations, Varying the Distribution Parameters
Fixed Parameters: Varying Parameter(s) Power
N = 1000, τ = 5, pi = 0.2, E[YC(0)] =
SD(YC(0)) = 8, SD(YC(1)) = 8, 0 0.45
p˙iNT = 0.4, E[YNT (0)] = −3, SD(YNT (0)) = 12, 10 0.35
p˙iAT = 0.4, E[YAT (1)] = 3, SD(YAT (1)) = 4 20 0.25
N = 1000, τ = 5, pi = 0.3, SD(YC(0)), SD(YC(1)) =
E[YC(0)] = 0, 8, 8 0.76
p˙iNT = 0.35, E[YNT (0)] = −3, SD(YNT (0)) = 12, 8, 16 0.63
p˙iAT = 0.35, E[YAT (1)] = 3, SD(YAT (1)) = 4 16, 16 0.52
N = 1000, τ = 5, pi = 0.2, E[YNT (0)], E[YAT (1)] =
E[YC(0)] = 0, SD(YC(0)) = 8, SD(YC(1)) = 8, −3, 3 0.44
p˙iNT = 0.4, SD(YNT (0)) = 12, 10, 3 0.26
p˙iAT = 0.4, SD(YAT (1)) = 4 10,−6 0.13
N = 1000, τ = 5, pi = 0.2, SD(YNT (0)), SD(YAT (1)) =
E[YC(0)] = 0, SD(YC(0)) = 8, SD(YC(1)) = 8, 12, 4 0.43
p˙iNT = 0.4, E[YNT (0)] = −3, 12, 8 0.37
p˙iAT = 0.4, E[YAT (1)] = 3 24, 8 0.15
N = 1000, τ = 5, pi, p˙iNT , p˙iAT =
E[YC(0)] = 0, SD(YC(0)) = 8, SD(YC(1)) = 8, 0.3, 0.35, 0.35 0.76
E[YNT (0)] = −3, SD(YNT (0)) = 12, 0.2, 0.4, 0.4 0.45
E[YAT (1)] = 3, SD(YAT (1)) = 4 0.2, 0.1, 0.7 0.71
0.2, 0.8, 0.0 0.30
impact on the power of the test.
Table B3 compares the test power of the Wald IV estimator with that of the difference-
in-means estimator of the ITT, highlighting a phenomenon recognized in previous work by
Jo (2002). Specifically, Table B3 varies the mean outcome values of the never-takers and
always-takers, holding all other parameters constant. As can be seen, the two test powers
change at different rates as these two principal strata means are altered. Depending upon
the specification, the power of the Wald IV estimator may be higher or lower than the power
of the ITT estimator. Table B3 demonstrates that a power analysis for the ITT cannot serve
as a replacement for a LATE power analysis.
Table B3: LATE vs. ITT Power Simulations
Fixed Parameters: Varying Parameter(s) PowerLATE PowerITT
E[YNT (0)], E[YAT (1)] =
N = 1000, τ = 5, pi = 0.2, −10, 10 0.34 0.25
E[YC(0)] = 0, SD(YC(0)) = 8, SD(YC(1)) = 8, −10, 3 0.38 0.30
p˙iNT = 0.4, SD(YNT (0)) = 12, −3, 3 0.44 0.41
p˙iAT = 0.4, SD(YAT (1)) = 4 10, 3 0.26 0.37
10,−6 0.13 0.30
Finally, Table B4 compares the power of the Wald IV estimator with the power implied
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by scaling a standard ATE power analysis. As described by previous studies (Duflo et al.,
2007; Baiocchi et al., 2014), one approach to performing a power analysis in the face of
noncompliance is by performing a simple ATE power analysis but scaling the variance of
the standard ATE difference-in-means estimator, specifically dividing it by the compliance
rate squared. This implies that, for a given treatment effect, the sample size required to
reach a particular power level in the full-compliance ATE context must be divided by the
compliance rate squared to offer the sample size required to reach that same power level in
the LATE context. For instance, if 100 observations are needed in the ATE context, then
approximately 100
0.22
= 2500 observations are required in the LATE context given a compliance
rate of 0.2. However, this approximate equality is only achieved given the strong assumptions
that (a) the never-takers have the same mean outcome value as the untreated compliers, (b)
the always-takers have the same mean outcome value as the treated compliers, and (c) all
groups have the same outcome variance. If any of those assumptions are violated, the true
power of the Wald IV estimator can diverge dramatically from the power implied by this
scaled ATE power analysis.
Table B4 demonstrates this result. Specifically, a standard ATE power analysis is per-
formed given a treatment effect of 5, a sample size of 100 (assigned equally to the treatment
and control groups), and within-group outcome standard deviation of 8. The resulting power
is 0.87, as indicated in the last column of the table. The other columns present the results
of additional LATE power simulations. For all of the simulations, the treatment effect and
within-group variances for the compliers are also set to 5 and 8, respectively, while the com-
pliance rate is set to 0.2. This implies that 100
0.22
= 2500 observations are required to reach
a power of 0.87, and thus all simulations are set with a sample size of 2500. The results in
the second and third columns of the table show that the power for the Wald IV estimator is
indeed about 0.87 when the appropriate distributional assumptions are met with regard to
the always-takers and never-takers (first specification). However, as the results also show, as
soon as those assumptions are violated, the scaled ATE power analysis provides extremely
unreliable guidance on power for the LATE.
Table B4: LATE vs. Scaled ATE Power Simulations
Fixed Parameters: Varying Parameter(s) PowerLATE Power Implied by
Scaled ATE Analysis
E[YNT (0)], E[YAT (1)],
SD(YNT (0)), SD(YAT (1)) =
N = 2500, τ = 5, pi = 0.2, 0, 5, 8, 8 0.87 ·
E[YC(0)] = 0, −10, 15, 8, 8 0.54 ·
SD(YC(0)) = 8, SD(YC(1)) = 8, 0, 5, 16, 16 0.39 0.87
p˙iNT = 0.4, p˙iAT = 0.4 −10, 15, 16, 16 0.32 ·
15,−10, 16, 16 0.19 ·
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Appendix C: Examples of Ordered Means Assumption (Y¯NT ≤ Y¯C ≤ Y¯AT )
Example 1: National JTPA Study (Bloom et al., 1997)
Table C1: Example 1 Results by Treatment Assignment and Uptake
Di = 0 Di = 1
Zi = 0 N = 3663 N = 54
Y¯ = 15062.99 Y¯ = 13515.26
Zi = 1 N = 2683 N = 4804
Y¯ = 13979.93 Y¯ = 17439.8
This example pertains to a well-known experimental study of the Job Training Partner-
ship Act of 1982 (Bloom et al., 1997), where study subjects were randomly assigned such
that they were either allowed to enroll in a job training program (assigned to the treatment)
or excluded from the training for an 18-month period (assigned to control). The dataset
used here is the tabulation of the JTPA study data by Abadie et al. (2002). The data
correspond to adult participants in the JTPA experiment for whom there was a measure-
ment of the outcome variable, which was earnings in the 30-month period after random
assignment. Table C1 separates the sample into four groups based on treatment assignment
(Z) and uptake (D). As shown in Table C1, there were almost no identified always-takers
(Zi = 0, Di = 1) in the National JTPA Study. As explained in Lemma 6, the alternat-
ive power lower bound can be used when Cov(E[Di|Xi], E[Yi|Xi]) is non-negative, where
Xi denotes the principal strata, which is true given the ordered means assumption that
Y¯NT ≤ Y¯C ≤ Y¯AT . However, given how few always-takers there are, they will have a negli-
gible influence on Cov(E[Di|Xi], E[Yi|Xi]), and hence the ordered means assumption can be
simplified to Y¯NT ≤ Y¯C as a practical matter.
There are 2683 identified never-takers (Zi = 1, Di = 0) in the study. Furthermore, this
group of identified never-takers exhibits the lowest mean observed outcome among the three
groups not including the identified always-takers. As a result, it is reasonable to conclude
that the ordered means assumption was met in this study.
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Example 2: New Haven Vote Canvassing Experiment (Gerber and Green, 2000, 2005)
Table C2: Example 2 Results by Treatment Assignment and Uptake
Di = 0 Di = 1
Zi = 0 N = 10733 N = 0
Y¯ = 0.442 Y¯ = NA
Zi = 1 N = 1781 N = 869
Y¯ = 0.435 Y¯ = 0.577
This example pertains a voter mobilization field experiment conducted by Gerber and
Green (2000) in 1998, using updated data from Gerber and Green (2005). The experiment
involved three different types of voter mobilization treatments—mailings, phone calls, and
home visits. The results presented here include those subjects assigned to receive no treat-
ments (pure control) and those subjects assigned only to the home visits, as this was the
treatment in which a major factor was noncompliance—i.e. not actually being contacted as
a result of the subject not being home. Subjects for whom the outcome (having voted in the
1998 midterm election) was missing are omitted.
As Table C2 shows, there is strict one-sided noncompliance by design in this study, with
no always-takers, thus simplifying the ordered means assumption to Y¯NT ≤ Y¯C . The results
are consistent with this assumption, as the identified never-takers (Zi = 1, Di = 0) have the
lowest mean outcome value.
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Example 3: Fuzzy Regression Discontinuity Design on the Effect of Naturalization on
Integration (Hainmueller et al., 2016)
Table C3: Example 3 Results by Treatment Assignment and Uptake
Di = 0 Di = 1
Zi = 0 N = 69 N = 90
Y¯ = −0.527 Y¯ = 0.048
Zi = 1 N = 0 N = 244
Y¯ = NA Y¯ = 0.055
This example pertains to a study on the effects of naturalization on the political integ-
ration of immigrants who applied for Swiss citizenship prior to 2003 (Hainmueller et al.,
2016),19 during which time certain municipalities used secret ballot referendums to vote on
which immigrants should be granted citizenship. As one of the identification and estimation
strategies, the study includes a fuzzy regression discontinuity design comparing only those
immigrants who barely received a majority “yes” vote and those who barely missed the ma-
jority. However, some of those immigrants who did not receive the majority vote initially
went on to gain citizenship later. As a result, a fuzzy regression discontinuity design can be
applied, where Z indicates having received the “yes” vote (assignment to treatment) and D
indicates having gained citizenship (uptake of the treatment).
The fuzzy regression discontinuity design (RDD) combines the machinery of the sharp
RDD and the LATE. The method of power analysis presented in this paper would be applic-
able to one particular estimator sometimes used with the fuzzy RDD, which is the standard
Wald IV estimator applied to subjects within the specified RDD bandwidth. However, while
the power method is technically not applicable to the actual fuzzy RDD regression estimat-
ors, it could be used as a convenient proxy.
As Table C3 shows, there is strict one-sided noncompliance by design in this study, with
no never-takers, thus simplifying the ordered means assumption to Y¯C ≤ Y¯AT . The identified
always-takers (Zi = 0, Di = 1) have almost the highest mean outcome value. However, the
mean outcome of the compliers would be the weighted average of the mean outcome of the
identified compliers in the (Zi = 0, Di = 0) group and the unidentified compliers in the
(Zi = 1, Di = 1). While we cannot identify the specific units in the latter group that are
compliers, rather than always-takers, we have information on the identified always-takers
(Zi = 0, Di = 1) and knowledge that the (Zi = 1, Di = 1) group is a mix of compliers and
19The data are not publicly available due to privacy concerns, and the statistics in Table C3 were provided
by the authors of the study. Individuals interested in accessing the data for replication purposes should
contact the authors.
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always-takers, which allows us to assess the ordered means assumption.
Specifically, treating Z as if randomized, we would expect the proportion of individuals
who are always-takers to be equal across the (Zi = 0) and (Zi = 1) margins. Thus, we can
estimate that approximately 138 of the individuals in the (Zi = 1, Di = 1) group are always-
takers, whose mean outcome should be the same (in expectation) as the mean outcome of
the identified always-takers in the (Zi = 0, Di = 1) group, which is 0.048. This implies that
the mean outcome of the unidentified compliers in the (Zi = 1, Di = 1) group, of which we
expect there should be 106, is approximately 0.064. As a result, the mean outcome of all
compliers would undoubtedly be lower than the mean outcome of always-takers, given the
particularly low value of the mean outcome for the identified compliers in the (Zi = 0, Di = 0)
group. Specifically, using the information we have, we can estimate the mean outcome of all
compliers to be −0.17. Thus, the results are consistent with the ordered means assumption.
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Appendix D: Power Plots
This section provides graphical illustrations of the relationships between power and the in-
vestigation parameters in the LATE power analysis method described above. Figures D1-D4
each contain a set of four plots. For each set, the x-axis plots a particular investigation
parameter while the y-axis plots either power or another investigation parameter. In ad-
dition, the compliance rate is varied across the four plots in each set. Every plot contains
three curves. The two solid curves correspond to the lower and upper bounds. The dashed
line corresponds to the alternative lower bound under Assumption 7 (ordered means). The
type-I error tolerance (α) is held constant at 0.05 for all plots.
Figure D1 plots the power against the effect size (κ). The sample size (N) is set to
1000 for all four plots in this figure, while the compliance rate (pi) varies between 0.2, 0.5,
0.8, and 1. In addition to showing the general rate at which power increases as the effect
size increases, the figure illustrates the importance of the compliance rate in shaping the
relationship between power and the effect size. First, it shows that the rate at which power
increases with the effect size is faster for higher compliance rates. For instance, for the
alternative lower bound (the dashed line), given pi = 0.2, a power of 0.8 is achieved only
when κ ≈ 1. In contrast, this power is achieved when κ ≈ 0.25 given pi = 0.8. In addition,
the figure also shows that the bounds converge as pi → 1. This makes intuitive sense: when
pi = 1 (i.e. full compliance), the LATE becomes the ATE, which does not require bounds to
characterize the power.
Figure D2 plots the power against the sample size (N), with κ held constant and pi
varying across plots as previously. As in Figure D1, Figure D2 shows a similar impact of the
compliance rate on the relationship between the sample size and power. Figures D3 and D4
plot the relationship between effect size and sample size, given a prespecified desired level
of power (held constant at 0.8). Again, the compliance rate varies across plots, illustrating
the importance of the compliance rate in determining the relationship between the other
parameters and the distance between the bounds.
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Figure D1: Power by Effect Size (with Varying Compliance Rate)
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Figure D2: Power by Sample Size (with Varying Compliance Rate)
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Figure D3: MDES by Sample Size (with Varying Compliance Rate)
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Figure D4: Sample Size by Effect Size (with Varying Compliance Rate)
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Appendix E: Simulation Results Given P (Zi = 1) = 0.25
Figure E1 compares simulated power curves to the analytic bounds given P (Zi = 1) = 0.25,
where power is plotted as a function of κ. As previously, the solid black lines denote the
analytic upper and lower bounds, while the dashed black line denotes the alternative lower
bound under the ordered means assumption. The colored lines denote power curves that were
simulated by specifying the full set of investigation and distribution parameters, and hence
simulating all three principal strata. The specifications are the same as those pertaining
to Figure 2 in the main text; the only difference is that P (Zi = 1) = 0.25, rather than
P (Zi = 1) = 0.5.
Figure E1: Simulated Power vs. Analytic Bounds, P (Zi = 1) = 0.25
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As Figure E1 illustrates, the analytic bounds derived for the general case where P (Zi =
1) = pz perform as well as the bounds derived for the special case of P (Zi = 1) = 0.5.
Compared to Figure 2, the power curves (analytic and simulated) in Figure E1 are all
slightly lower, which makes sense given that the decrease in P (Zi = 1) means a less balanced
allocation of treatment uptake among the compliers. Similar to Figure 2, the alternative
lower bound (the dashed black line) in Figure E1 bounds the appropriate simulated curves.
For specifications 1 and 2, Assumption 7 (ordered means) is met at all values of κ, and hence
the alternative lower bound applies. Accordingly, the curves for these specifications again
lie above the alternative lower bound. In contrast, the ordered means assumption is violated
by specifications 4 and 5 at all values of κ, and again these curves appropriately lie below
the alternative lower bound.
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Appendix F: Incorporating Covariates
The bounds on the variance of the estimator presented in Lemma 3 (see Appendix A) provide
a convenient framework for incorporating the gains in precision achieved through covariate
adjustment, which can be quantified in terms of R2 values, as presented elsewhere (e.g.
Bloom et al., 2007).
As presented in the main body of the paper, define the following R2 values:
R2DW =
σ2 − σ∗2
σ2
R2YW =
ω2 − ω∗2
ω2
where σ2 = E[ν2i ] as defined in the proof of Proposition 1, ω
2 = E[ζ2i ] as defined in the proof
of Proposition 1, σ∗2 = E[ν∗2i ] from equation (1), and ω
∗2 = E[ζ∗2i ] from equation (2).
R2DW measures the proportion of variation in D left unexplained by Z that is explained
by the covariates contained in W, while R2YW measures the proportion of variation in Y
left unexplained by Z that is explained by the covariates contained in W. This definition
can also be re-expressed as σ∗2 = (1− R2DW )σ2 and ω∗2 = (1− R2YW )ω2, where σ∗2 and ω∗2
measure the remaining unexplained variation in D and Y after adjusting for Z and W.
The result is that, if a researcher plans to measure relevant covariates and has know-
ledge about anticipated R2DW and R
2
YW values based on previous research or subject matter
expertise, these values can then be used to further modify the power bounds of the 2SLS
estimator of the LATE. Specifically, the variance bounds in Lemma 3 would now be based
on σ∗2 and ω∗2 rather than σ2 and ω2. That is, the bounds in Lemma 3 become:
V 2̂SLSN bounds :
ω∗2 + τ 2σ∗2 ± 2τσ∗ω∗
0.25Npi2
=
(1−R2YW )ω2 + τ 2(1−R2DW )σ2 ± 2τ
√
(1−R2DW )(1−R2YW )σω
0.25Npi2
=
(1−R2YW )E[ζ2i ] + τ 2(1−R2DW )E[ν2i ]± 2τ
√
(1−R2DW )(1−R2YW )E[ζ2i ]E[ν2i ]
0.25Npi2
In contrast, ω2 = E[ζ2i ] is not replaced by ω
∗2 = E[ζ∗2i ] in Lemma 4 because the results
of Lemma 4 continue to follow from conditioning on Z alone. The resulting power bounds
can then be derived as before, now simply taking into account the scalars (1 − R2DW ) and
(1−R2YW ) introduced into the bounds on the estimator variance. The result is the following:
τ√
V 2̂SLSN
bounds :
√
0.25κ2Npi2
(1−R2YW ) + κ2(1−R2DW )E[ν2i ]± 2κ
√
(1−R2YW )(1−R2DW )E[ν2i ]
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These bounds can be plugged into the power formula Φ
(
−c∗ + τ√
V 2̂SLSN
)
+Φ
(
−c∗ − τ√
V 2̂SLSN
)
=
1 − β. As previously, the bounds can be modified to both relax Assumption 6 (equal as-
signment probability) and employ Assumption 7 (ordered means), and E[ν2i ] replaced with
either (0.5− pi
2
)(0.5 + pi
2
) or 0.25 depending on whether Assumption 6 is made.
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